Next Article in Journal
Detailed Characterization of the Lung–Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients
Previous Article in Journal
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Previous Article in Special Issue
A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations
 
 
Communication
Peer-Review Record

High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures

Int. J. Mol. Sci. 2024, 25(4), 2321; https://doi.org/10.3390/ijms25042321
by Álvaro del Real 1, Raquel Cruz 2, Carolina Sañudo 1, José L. Pérez-Castrillón 3, María I. Pérez-Núñez 4, Jose M. Olmos 1,5, José L. Hernández 1,5, Carmen García-Ibarbia 5, Carmen Valero 1,5 and Jose A. Riancho 1,5,6,*
Reviewer 1:
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2024, 25(4), 2321; https://doi.org/10.3390/ijms25042321
Submission received: 22 January 2024 / Revised: 10 February 2024 / Accepted: 13 February 2024 / Published: 15 February 2024
(This article belongs to the Special Issue Molecular Advances in Osteoporosis Study)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Review Comments

 

The authors conducted an interesting study using WES to find the plausible associations of structural variants with AFF pathogenesis. The Introduction is well-written, also, methods and Discussion. However, this is an interesting work, it needs minor revision.

 

#Comment 1: Please reconsider about your title; it is better to change into this: High frequencies of genetic variants in patients with atypical femoral fractures

#Comment 2: The authors did not mention about the variants themselves in any part of the paper. A table for variants is needed with the columns containing chromosome location, Ref allele, Altered allele, Variant type [function: missense, missense+regulatory, etc. ], HGVS,  RS ID, and Gene Symbol. This should be added to the results section.

 

#Comment 3: The authors should mention about the ACMG classification of each variant and discuss about the ClinVar report(s) for each variant. The ACMG classification define the level of pathogenicity of the variants; for example, some variants might be Pathogenic, or Likely Pathogenic or even a strong VUS. The authors can add a column in the Comment 1 table entitled “ACMG classification”. They would be able to widen the genetic standpoint of the paper. This classification will help the paper to prioritize the variants, consequently, the level of paper will increase and more special.

 

#Comment 4: Discuss about the variants and their functions, this can be described by the residue changes, INDEL, stop-gained, stop-lost, etc. Check the variant locations for finding any regulatory region that a variant may play role. This will help to make questions about the transcriptomic roles of these variants in AFF.

 

 

Comment 5: In discussion section, the authors emphasized on the pathways of genes involved in the AFF pathogenicity, but did not perform any signaling-based analysis; thus, it is highly recommended that the authors should carry out a bioinformatics-based analysis for their suggested genes. This will increase the reliability and validity of their findings. There are well-known applications such as Cytoscape and Enrichr. The authors will be able to discuss about the signaling-based outputs and suggest valuable strengthening clues or suggesting future studies to investigate the possible gaps. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

This study describes a whole exome sequencing analysis of the variants contributing to atypical femoral fractures in anti-resorptive therapy. It concludes that a heterogeneity in the accumulation of gene variants that regulate osteogenesis, rather than pathogenic variants, present a risk for susceptibility to atypical femoral fractures when compared to osteoporosis patients and a general population database.

The study is well-presented and easy to follow for someone with limited experience in genomic approaches. One minor point of interest:

1.    The discussion of the osteogenic genes on page 4 is good. For biologists, could the authors offer a general comment on any trends on the nature of the variants within the osteogenic gene groups?

 Are the variations SNPs, insertions/deletions, alternative splicing, etc?

Are variants conservative or non-conservative changes from the control

groups?

How might variants affect the protein function, such as accumulated variants

skewed toward exons specifying an extracellular binding domain versus a

signaling domain?

 

This reviewer acknowledges that a detailed description of different gene variants

might be outside the scope of this manuscript.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop